IL6 and cancer: Among the pro-inflammatory cytokines, IL-1β, IL-6, and IL-12 showed the most robust differences, with IL-1β showing a maximum plasma concentration of 182 pg/mL in cancer patients, compared to 3 pg/mL in controls.